Hepatitis News : Hepatitis C Antiviral Treatments May Prevent Liver Cancer
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis News » October 2012


emailprint

October 29, 2012

Hepatitis C Antiviral Treatments May Prevent Liver Cancer

A recent study suggests that hepatitis C virus (HCV) antiviral treatment may prevent liver cancer in people with HCV, nearly cutting in half the rates of the cancer for those with fibrosis or cirrhosis. Published online in BMJ Open and first reported by MedPage Today, the study was conducted by researchers at the University Hospital Hvidovre in Denmark. The scientists performed a meta-analysis of eight randomized controlled trials that compared antiviral therapy—interferon or pegylated interferon as monotherapy or paired with ribavirin—to a placebo or no antiviral treatment. Further analysis showed that those who respond well to hep C treatment have even lower rates of liver cancer. The trial was limited by the outdated nature of the treatments studied: Only two of the trials used the current standard treatment of pegylated interferon rather than regular interferon; and most of the trials involved monotherapy. While the researchers wrote that it was difficult to apply their results into clinical practice, they did speculate that with ever-improving HCV treatments, liver cancer rates will likely fall in tandem with improved virologic responses.

To read the MedPage Today article, click here.

To download a PDF of the study, click here.

Search: HCV, hepatitis C, hep C, treatment, antiviral, pegylated interferon, interferon, ribaviron, liver cancer, virologic response, fibrosis, cirrhosis


Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)


[Go to top]

QUICK LINKS

Current Issue
Forums
Poll
Blogs
Hep Stories
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Have you gotten headaches while on hep C treatment?
Yes
No


Survey
Hepatitis C Reader Survey
HEP ON TWITTER
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.